These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26673327)

  • 41. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
    Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
    Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. mTOR transcriptionally and post-transcriptionally regulates Npm1 gene expression to contribute to enhanced proliferation in cells with Pten inactivation.
    Boudra R; Lagrafeuille R; Lours-Calet C; de Joussineau C; Loubeau-Legros G; Chaveroux C; Saru JP; Baron S; Morel L; Beaudoin C
    Cell Cycle; 2016 May; 15(10):1352-62. PubMed ID: 27050906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Theoretical studies on RNA recognition by Musashi 1 RNA-binding protein.
    Darai N; Mahalapbutr P; Wolschann P; Lee VS; Wolfinger MT; Rungrotmongkol T
    Sci Rep; 2022 Jul; 12(1):12137. PubMed ID: 35840700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.
    Vo DT; Qiao M; Smith AD; Burns SC; Brenner AJ; Penalva LO
    RNA Biol; 2011; 8(5):817-28. PubMed ID: 21881409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
    Liu X; Yang WT; Zheng PS
    Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TSC1/TSC2 inactivation inhibits AKT through mTORC1-dependent up-regulation of STAT3-PTEN cascade.
    Zha X; Hu Z; He S; Wang F; Shen H; Zhang H
    Cancer Lett; 2011 Dec; 313(2):211-7. PubMed ID: 22055460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Constitutive Musashi1 expression impairs mouse postnatal development and intestinal homeostasis.
    Chiremba TT; Neufeld KL
    Mol Biol Cell; 2021 Jan; 32(1):28-44. PubMed ID: 33175598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
    Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
    J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
    Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
    J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
    Li H; Zhang J; Lee MJ; Yu GR; Han X; Kim DG
    Oncotarget; 2017 Mar; 8(11):18129-18144. PubMed ID: 28184024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis.
    Gao F; Alwhaibi A; Sabbineni H; Verma A; Eldahshan W; Somanath PR
    Cancer Lett; 2017 Aug; 402():177-189. PubMed ID: 28602980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors.
    Lee D; Sykes SM; Kalaitzidis D; Lane AA; Kfoury Y; Raaijmakers MH; Wang YH; Armstrong SA; Scadden DT
    Stem Cell Reports; 2014 Nov; 3(5):832-40. PubMed ID: 25418727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo.
    Sharon C; Baranwal S; Patel NJ; Rodriguez-Agudo D; Pandak WM; Majumdar AP; Krystal G; Patel BB
    Oncotarget; 2015 Jun; 6(17):15332-47. PubMed ID: 25895029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Class I PI3-kinase or Akt inhibition do not impair axonal polarization, but slow down axonal elongation.
    Diez H; Benitez MJ; Fernandez S; Torres-Aleman I; Garrido JJ; Wandosell F
    Biochim Biophys Acta; 2016 Nov; 1863(11):2574-2583. PubMed ID: 27421985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LZTS2 and PTEN collaboratively regulate ß-catenin in prostatic tumorigenesis.
    Yu EJ; Hooker E; Johnson DT; Kwak MK; Zou K; Luong R; He Y; Sun Z
    PLoS One; 2017; 12(3):e0174357. PubMed ID: 28323888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Msi1 promotes tumor progression by epithelial-to-mesenchymal transition in cervical cancer.
    Gong P; Wang Y; Gao Y; Gao M; Liu L; Qu P; Jin X; Gao Q
    Hum Pathol; 2017 Jul; 65():53-61. PubMed ID: 28088346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Downregulation of Msi1 suppresses the growth of human colon cancer by targeting p21cip1.
    Gao C; Han C; Yu Q; Guan Y; Li N; Zhou J; Tian Y; Zhang Y
    Int J Oncol; 2015 Feb; 46(2):732-40. PubMed ID: 25394506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.